Literature DB >> 15677572

Association between a functional variant of the KLOTHO gene and high-density lipoprotein cholesterol, blood pressure, stroke, and longevity.

Dan E Arking1, Gil Atzmon, Albert Arking, Nir Barzilai, Harry C Dietz.   

Abstract

We previously identified a functional variant of KLOTHO, termed KL-VS, that is associated with human aging and early-onset occult coronary artery disease. Here, we determine whether the KL-VS allele influences cardiovascular disease risk factors, cardiovascular events, and ultimately, mortality. A total of 525 Ashkenazi Jews composed of 216 probands (age > or =95 years) and 309 unrelated individuals (ages 51 to 94) were genotyped for the KL-VS allele. In concordance with our previous data in Czech individuals (age > or =79; P<0.01), a heterozygous advantage for longevity was observed for individuals > or =79 years of age (P<0.004). Combined analysis indicates a 1.57-fold (95% CI, 1.23 to 1.98) increased odds ratio (OR) for 5-year survival in two independent populations (P<0.0002). Cardiovascular disease risk factors were assessed through multivariate regression analysis, demonstrating that high-density lipoprotein cholesterol (HDL-C; P<0.05) and systolic blood pressure (SBP; P<0.008) are associated with KL-VS genotype. History of vascular events was analyzed using logistic regression, indicating that after adjustment for traditional risk factors, heterozygous individuals were at significantly lower risk for stroke than wild-type individuals (OR, 5.88; 95% CI, 1.18 to 29.41), whereas homozygous KL-VS individuals had the highest risk (OR, 30.65; 95% CI, 2.55 to 368.00). Similarly, prospective analysis of mortality in probands using Cox regression indicates that wild-type individuals have a 2.15-fold (95% CI, 1.18 to 3.91) and homozygous KL-VS individuals a 4.49-fold (95% CI, 1.35 to 14.97) increase in relative risk for mortality after adjusting for potential confounders. Thus, cross-sectional and prospective studies confirm a genetic model in which the KL-VS allele confers a heterozygous advantage in conjunction with a marked homozygous disadvantage for HDL-C levels, SBP, stroke, and longevity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15677572     DOI: 10.1161/01.RES.0000157171.04054.30

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  109 in total

1.  Human longevity and variation in GH/IGF-1/insulin signaling, DNA damage signaling and repair and pro/antioxidant pathway genes: cross sectional and longitudinal studies.

Authors:  Mette Soerensen; Serena Dato; Qihua Tan; Mikael Thinggaard; Rabea Kleindorp; Marian Beekman; Rune Jacobsen; H Eka D Suchiman; Anton J M de Craen; Rudi G J Westendorp; Stefan Schreiber; Tinna Stevnsner; Vilhelm A Bohr; P Eline Slagboom; Almut Nebel; James W Vaupel; Kaare Christensen; Matt McGue; Lene Christiansen
Journal:  Exp Gerontol       Date:  2012-03-03       Impact factor: 4.032

2.  Linkage and association of successful aging to the 6q25 region in large Amish kindreds.

Authors:  Digna R Velez Edwards; John R Gilbert; James E Hicks; Jamie L Myers; Lan Jiang; Anna C Cummings; Shengru Guo; Paul J Gallins; Ioanna Konidari; Laura Caywood; Lori Reinhart-Mercer; Denise Fuzzell; Claire Knebusch; Renee Laux; Charles E Jackson; Margaret A Pericak-Vance; Jonathan L Haines; William K Scott
Journal:  Age (Dordr)       Date:  2012-07-07

3.  Promoter methylation confers kidney-specific expression of the Klotho gene.

Authors:  Masahiro Azuma; Daisuke Koyama; Jiro Kikuchi; Hiromichi Yoshizawa; Dissayabutra Thasinas; Kazuhiro Shiizaki; Makoto Kuro-o; Yusuke Furukawa; Eiji Kusano
Journal:  FASEB J       Date:  2012-07-10       Impact factor: 5.191

4.  A meta-analysis of four genome-wide association studies of survival to age 90 years or older: the Cohorts for Heart and Aging Research in Genomic Epidemiology Consortium.

Authors:  Anne B Newman; Stefan Walter; Kathryn L Lunetta; Melissa E Garcia; P Eline Slagboom; Kaare Christensen; Alice M Arnold; Thor Aspelund; Yurii S Aulchenko; Emelia J Benjamin; Lene Christiansen; Ralph B D'Agostino; Annette L Fitzpatrick; Nora Franceschini; Nicole L Glazer; Vilmundur Gudnason; Albert Hofman; Robert Kaplan; David Karasik; Margaret Kelly-Hayes; Douglas P Kiel; Lenore J Launer; Kristin D Marciante; Joseph M Massaro; Iva Miljkovic; Michael A Nalls; Dena Hernandez; Bruce M Psaty; Fernando Rivadeneira; Jerome Rotter; Sudha Seshadri; Albert V Smith; Kent D Taylor; Henning Tiemeier; Hae-Won Uh; André G Uitterlinden; James W Vaupel; Jeremy Walston; Rudi G J Westendorp; Tamara B Harris; Thomas Lumley; Cornelia M van Duijn; Joanne M Murabito
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2010-03-18       Impact factor: 6.053

Review 5.  The role of Klotho in energy metabolism.

Authors:  M Shawkat Razzaque
Journal:  Nat Rev Endocrinol       Date:  2012-05-29       Impact factor: 43.330

6.  High-fat-diet-induced obesity and heart dysfunction are regulated by the TOR pathway in Drosophila.

Authors:  Ryan T Birse; Joan Choi; Kathryn Reardon; Jessica Rodriguez; Suzanne Graham; Soda Diop; Karen Ocorr; Rolf Bodmer; Sean Oldham
Journal:  Cell Metab       Date:  2010-11-03       Impact factor: 27.287

Review 7.  Klotho and aging.

Authors:  Makoto Kuro-o
Journal:  Biochim Biophys Acta       Date:  2009-02-20

8.  Klotho in the cerebrospinal fluid of adults with and without Alzheimer's disease.

Authors:  Richard D Semba; Abhay R Moghekar; Jason Hu; Kai Sun; Randi Turner; Luigi Ferrucci; Richard O'Brien
Journal:  Neurosci Lett       Date:  2013-11-07       Impact factor: 3.046

9.  Biochemical and functional characterization of the klotho-VS polymorphism implicated in aging and disease risk.

Authors:  Tracey B Tucker Zhou; Gwendalyn D King; CiDi Chen; Carmela R Abraham
Journal:  J Biol Chem       Date:  2013-11-11       Impact factor: 5.157

10.  Life extension factor klotho enhances cognition.

Authors:  Dena B Dubal; Jennifer S Yokoyama; Lei Zhu; Lauren Broestl; Kurtresha Worden; Dan Wang; Virginia E Sturm; Daniel Kim; Eric Klein; Gui-Qiu Yu; Kaitlyn Ho; Kirsten E Eilertson; Lei Yu; Makoto Kuro-o; Philip L De Jager; Giovanni Coppola; Gary W Small; David A Bennett; Joel H Kramer; Carmela R Abraham; Bruce L Miller; Lennart Mucke
Journal:  Cell Rep       Date:  2014-05-10       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.